… -led piperacillin-tazobactam extended 4-hour infusion guideline was implemented
hospital-wide at a 500-bed academic medical center. Each piperacillin-tazobactam infusion was …

… D, are acknowledged for their helpful advice regarding the development of the piperacillin–tazobactam
extended-infusion program. Lynley Heinrich and Chris Edwards are …

BACKGROUND: Use of extended infusions of piperacillin/tazobactam (PT) in adult patients
has been described, but data in children are limited. OBJECTIVE: The goal of this study was …

… In recent years there have been fewer novel antimicrobial agents developed which has been
compounded … These adverse outcomes have led clinicians to develop ways to optimize the …

… The pre-implementation group received a mean of 5.22 days of PT, … post-implementation
group (P = 0.224). Ten per cent (12/115) of patients in the pre-implementation group developed …

SciELO - Brasil - Impact of piperacillin-tazobactam shortage on meropenem use: implications
for antimicrobial stewardship programs Impact of piperacillin-tazobactam shortage on …

… models developed for piperacillin-tazobactam and provides … of drugs, such as
piperacillin-tazobactam, resulting in … proportion of clinicians seek their implementation for this …

… , and we advocate the development of multiple piperacillin-tazobactam dose ratio formulations,
as … This platform is relatively easy to implement clinically and may be instrumental to the …

Objectives A better dosing strategy can improve clinical outcomes for patients. We sought to
compare the extended or continuous infusion with conventional intermittent infusion of …

… developed from an understanding of the pharmacokinetic and pharmacodynamic profiles of
piperacillin– tazobactam … for the implementation of EI policies for piperacillin– tazobactam in …